COVID‐19‐associated mucormycosis: an updated systematic review of literature
In its wake, the COVID‐19 pandemic has ushered in a surge in the number of cases of
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …
mucormycosis. Most cases are temporally linked to COVID‐19; hence, the entity is described …
[PDF][PDF] Coronavirus disease-associated mucormycosis from a tertiary care hospital in India: a case series
Background: Coronavirus disease (COVID-19) remains a health concern with new
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …
challenges emerging as the pandemic progresses. The recent rise of opportunistic infections …
[HTML][HTML] COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management
The coronavirus disease 2019 (COVID-19) outbreak has caused significant destruction,
claiming over three million lives worldwide. Post SARS-COV-2 invasion …
claiming over three million lives worldwide. Post SARS-COV-2 invasion …
[HTML][HTML] COVID-19-associated mucormycosis (CAM): an updated evidence mapping
Mucormycosis, a serious and rare fungal infection, has recently been reported in COVID-19
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …
Mucormycosis and COVID‐19: an epidemic within a pandemic in India
L Selarka, S Sharma, D Saini, S Sharma, A Batra… - Mycoses, 2021 - Wiley Online Library
Abstract Importance Coronavirus disease (COVID‐19) causes an immunosuppressed state
and increases risk of secondary infections like mucormycosis. We evaluated clinical …
and increases risk of secondary infections like mucormycosis. We evaluated clinical …
COVID-19-associated mucormycosis presenting to the Emergency Department—an observational study of 70 patients
Background Mucormycosis (MM) is a deadly opportunistic fungal infection and a large surge
in COVID-19-associated mucormycosis (CAM) is occurring in India. Aim Our aim was to …
in COVID-19-associated mucormycosis (CAM) is occurring in India. Aim Our aim was to …
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
D Seidel, M Simon, R Sprute, M Lubnow, K Evert… - Mycoses, 2022 - Wiley Online Library
Background Most COVID‐19‐associated mucormycosis (CAM) cases are reported from
India and neighbouring countries. Anecdotally cases from Europe have been presented …
India and neighbouring countries. Anecdotally cases from Europe have been presented …
Coronavirus disease 2019–associated mucormycosis: risk factors and mechanisms of disease
S Narayanan, JV Chua… - Clinical Infectious Diseases, 2022 - academic.oup.com
The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
COVID-19-associated mucormycosis: Case report and systematic review
A Dilek, R Ozaras, S Ozkaya, M Sunbul, EI Sen… - Travel medicine and …, 2021 - Elsevier
Background Increasing number of patients with COVID-19-associated mucormycosis have
been reported, especially from India recently. We have described a patient with COVID-19 …
been reported, especially from India recently. We have described a patient with COVID-19 …
[HTML][HTML] Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …